In the BioHarmony Drug Report Database

"Preview" Icon

Dexlansoprazole

Dexilant, Dexilant Solutab (dexlansoprazole) is a small molecule pharmaceutical. Dexlansoprazole was first approved as Dexilant on 2009-01-30. It is used to treat gastroesophageal reflux, heartburn, and peptic esophagitis in the USA. Dexilant’s patents are valid until 2032-03-05 (FDA).

 

Trade Name

 

Dexilant, Dexilant Solutab
 

Common Name

 

dexlansoprazole
 

ChEMBL ID

 

CHEMBL1201863
 

Indication

 

gastroesophageal reflux, heartburn, peptic esophagitis
 

Drug Class

 

Antiulcer agents (benzimidazole derivatives)

Image (chem structure or protein)

Dexlansoprazole structure rendering